Clinical Trial: Expanded Access to Avelumab for Treatment of Metastatic Merkel Cell Carcinoma (mMCC)

Study Status: Available
Recruit Status: Available
Study Type: Expanded Access




Official Title: Temporary Authorization for Use (ATU) to Avelumab for Treatment of Adult Patients With Metastatic Merkel Cell Carcinoma (mMCC)

Brief Summary: Expanded access to Avelumab solution for infusion will be made available for adult patients with mMCC whose disease has progressed after receiving at least one prior chemotherapy.